Revance Therapeutics, Inc.

BLAIR WILLIAM & CO/IL

Report date

12/31/2024

Quarter

2024 Q4

Filed

2/12/2025

Shares

88,295

Value ($000)

268

Weight

0.0%

2019 Q4 - 2024 Q4 (21 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2024 Q4	2/12/2025	268	0.0%	88,295	12/31/2024
2024 Q3	11/12/2024	446	0.0%	85,998	9/30/2024
2024 Q2	8/12/2024	747	0.0%	290,515	6/30/2024
2024 Q1	5/9/2024	1,620	0.0%	329,267	3/31/2024
2023 Q4	2/12/2024	2,575	0.0%	292,949	12/31/2023
2023 Q3	11/9/2023	3,743	0.0%	326,306	9/30/2023
2023 Q2	8/11/2023	12,561	0.0%	496,275	6/30/2023
2023 Q1	5/12/2023	9,885	0.0%	306,877	3/31/2023
2022 Q4	2/10/2023	2,317	0.0%	125,505	12/31/2022
2022 Q3	11/9/2022	2,978	0.0%	110,305	9/30/2022
2022 Q2	8/10/2022	196	0.0%	14,193	6/30/2022
2022 Q1	5/13/2022	247	0.0%	12,651	3/31/2022
2021 Q4	2/14/2022	211	0.0%	12,951	12/31/2021
2021 Q3	11/12/2021	2,960	0.0%	106,231	9/30/2021
2021 Q2	8/12/2021	2,094	0.0%	70,634	6/30/2021
2021 Q1	5/13/2021	1,160	0.0%	41,514	3/31/2021
2020 Q4	2/9/2021	580	0.0%	20,481	12/31/2020
2020 Q3	11/6/2020	273	0.0%	10,841	9/30/2020
2020 Q2	8/12/2020	555	0.0%	22,736	6/30/2020
2020 Q1	5/11/2020	277	0.0%	18,700	3/31/2020
2019 Q4	2/13/2020	251	0.0%	15,450	12/31/2019